Skip to main content
Fig. 6 | EJNMMI Research

Fig. 6

From: Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer

Fig. 6

Targeting uPAR for molecular imaging. a Representation of binding domains of the uPAR imaging agents currently under development, their classification and suitable imaging modality. b Positive primary lesion with uPAR PET in human prostate cancer after injection of 64Cu-DOTA-AE105. Images adapted from Skovgaard et al. [218] and used under the terms of the Creative Commons CC BY license. c NIR optical imaging of orthotopic colon cancer with hybrid ATN-658

Back to article page